S5013

Salbutamol hemisulfate salt

≥98%

• Synonyme(s) : α-([t-Butylamino]methyl)-4-hydroxy-m-xylene-α,α′-diol, Albuterol
• Formule linéaire : C₁₃H₂₁NO₃ · 1/2H₂SO₄
• Numéro CAS: 51022-70-9
• Poids moléculaire : 288.35
• NACRES: NA.77
• PubChem Substance ID: 24277746
• UNSPSC Code: 12352200
• EC Number: 256-916-8
• MDL number: MFCD00055200
• Assay: ≥98%

Propriétés

• Quality Segment: 200
• assay: ≥98%
• solubility: 1 M NaOH: 50 mg/ml, clear to slightly hazy, yellow-green
• originator: GlaxoSmithKline
• SMILES string: OS(O)(=O)=O.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c2ccc(O)c(CO)c2
• InChI: 1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)
• InChI key: BNPSSFBOAGDEEL-UHFFFAOYSA-N
• Gene Information: human ... ADRB2(154)

Description

Application

Salbutamol hemisulfate salt was used as standard in analysis of fortified meat for LABA content using ELISA kits.³ It was used to study the response of prostaglandin 2α to various β-adrenergic agonists in cultured bovine endometrial cells.⁴

Salbutamol hemisulfate salt has been used as reference standards of drugs for the validation of β-agonist residue.

Biochem/physiol Actions

β2-Adrenergic receptor agonist.

Salbutamol is a β2 adrenoceptor agonist with short acting bronchodilation and anti-inflammatory effects. It relaxes the airway smooth muscles and inhibits bronchoconstriction induced by adenosine-5′ -monophosphate (AMP).¹ Salbutamol is particularly effective in treatment of asthma as it provides immediate relief.²

Salbutamol is a β2 adrenoceptor agonist with short acting bronchodilation and anti-inflammatory effects. It relaxes the airway smooth muscles and inhibits bronchoconstriction induced by adenosine-5′ -monophosphate (AMP). Salbutamol is particularly effective in treatment of asthma as it provides immediate relief. Salbutamol is one of the most popular short-acting BA (SABA). It is useful in treating the symptoms of EIB (exercise induced bronchospasm).

Features and Benefits

This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Informations sur la sécurité

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H317,H351,H361fd
• pcodes: P202 - P261 - P272 - P280 - P302 + P352 - P308 + P313
• Hazard Classifications: Carc. 2 - Repr. 2 - Skin Sens. 1
• Classe de stockage: 11 - Combustible Solids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)